Personal profile
Biography
Dr. Lynn Yap is an interdisciplinary stem cell biologist who graduated with Ph.D. from NUS Graduate School for Integrative Sciences and Engineering. She had her post-doctoral training with Professor Karl Tryggvason at Duke-NUS Medical School. At Duke-NUS, she codeveloped the laminin-derived cardiovascular progenitor technology for the treatment of ischemic cardiomyopathy which led to a family of patents in regenerative cardiology. Her invention has been out-licensed to the Swedish biotechnology company, Alder Therapeutics, which will use it to produce GMP-grade cardiac progenitors for phase 1 clinical trials. She received the Khoo Teck Puat post-doctoral fellowship and the Goh cardiovascular research award, and she actively participated in the NRF-CRP project for regenerative medicine.
Currently, Dr. Yap is an Assistant Professor of Cardiometabolic Medicine at Lee Kong Chian School of Medicine and holds a joint appointment with the National Heart Research Institute Singapore. The overall goal of her research program is to uncover the molecular and physiological mechanisms underpinning stem cell-based therapy for regenerative cardiology. Through innovative discoveries and inventions, Dr. Yap hopes to shape future healthcare and medicine. She is a member of the International Society of Stem Cell Research, the Early Career Advisory Group for eLife Sciences Publications, and a co-founder of Alder Therapeutics.